Crossmark

Somatotropinomas inadequately controlled with octreotide may over-respond to pasireotide: the importance of dose adjustment to achieve long-term biochemical control

Crossref DOI link: https://doi.org/10.14310/horm.2002.1722

Published Online: 2017-02-28

Published Print: 2017-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Shimon, Ilan

Saeger, Wolfgang

Wildemberg, Luiz Eduardo

Gadelha, Monica R.
License Information

Text and Data Mining valid from 2017-01-01

Version of Record valid from 2017-01-01
More Information

Article History

Received: 31 January 2017

Accepted: 22 February 2017

First Online: 28 February 2017

Free to read: This content has been made available to all.

Document is current

Any future updates will be listed below